drugset / Trial / NCT02348658

A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet

NCT02348658 ↗

Phase 1 Completed 12 enrolled Takeda
RandomizedCrossoverOpen-labelTreatment

Summary

This is a phase 1, randomized, open-label, crossover study to evaluate the food-effect of single oral dose of TAK-536TCH final formulation tablet in healthy adult male participants.

Timeline

Start
2015-01
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject TAK-536TCH Unknown — Oral

Indications